Literature DB >> 13834553

Detection in normal urine of protein resembling Bence Jones protein.

G T STEVENSON.   

Abstract

Keywords:  PROTEINS/urine

Mesh:

Substances:

Year:  1960        PMID: 13834553      PMCID: PMC441864          DOI: 10.1172/JCI104134

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  16 in total

1.  Immunologic differences between the 19 S and 7 S components of normal human gamma-globulin.

Authors:  E C FRANKLIN; H G KUNKEL
Journal:  J Immunol       Date:  1957-01       Impact factor: 5.422

2.  Proteins in multiple myeloma. VII. The free amino groups of Bence-Jones proteins.

Authors:  F W PUTNAM; A MIYAKE
Journal:  J Biol Chem       Date:  1957-08       Impact factor: 5.157

3.  The proteins of normal urine.

Authors:  G H GRANT
Journal:  J Clin Pathol       Date:  1957-11       Impact factor: 3.411

4.  Immunochemical relation of Bence-Jones proteins to normal serum proteins.

Authors:  H F DEUTSCH; C H KRATOCHVIL; A E REIF
Journal:  J Biol Chem       Date:  1955-09       Impact factor: 5.157

5.  Carcinoma of the bronchus with Bence Jones proteinuria.

Authors:  J T HUGHES
Journal:  Br Med J       Date:  1954-11-27

6.  A micro biuret method for protein determination; determination of total protein in cerebrospinal fluid.

Authors:  J GOA
Journal:  Scand J Clin Lab Invest       Date:  1953       Impact factor: 1.713

7.  [Method permitting the combined study of the electrophoretic and the immunochemical properties of protein mixtures; application to blood serum].

Authors:  P GRABAR; C A WILLIAMS
Journal:  Biochim Biophys Acta       Date:  1953-01

8.  The precipitin test for Bence-Jones protein.

Authors:  F C COLLIER; P JACKSON
Journal:  N Engl J Med       Date:  1953-03-05       Impact factor: 91.245

9.  Multiple myeloma. IV. Abnormal serum components and Bence Jones protein.

Authors:  R W RUNDLES; G R COOPER; R W WILLETT
Journal:  J Clin Invest       Date:  1951-10       Impact factor: 14.808

10.  An unusual case of hyperglobulinaemia.

Authors:  A S MCFARLANE; A DOVEY
Journal:  J Pathol Bacteriol       Date:  1952-04
View more
  14 in total

1.  CHARACTERIZATION OF ANTIBODIES IN HUMAN URINE.

Authors:  L A HANSON; E M TAN
Journal:  J Clin Invest       Date:  1965-05       Impact factor: 14.808

2.  Further studies of the gamma-related proteins of normal urine.

Authors:  G T STEVENSON
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

3.  Normal counterparts to Bence-Jones proteins: free L polypeptide chains of human gamma-globulin.

Authors:  I BERGGARD; G M EDELMAN
Journal:  Proc Natl Acad Sci U S A       Date:  1963-03-15       Impact factor: 11.205

4.  Formation of Bence-Jones protein and myeloma protein in vitro by the plasma-cell tumour MPC-2.

Authors:  B A ASKONAS; J L FAHEY
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

5.  [Dys- and paraproteinemias in amyloidosis].

Authors:  F W Aly; H J Braun; H P Missmahl
Journal:  Klin Wochenschr       Date:  1968-07-15

6.  [The optical rotation dispersion of isolated parapro- teins. II. On group specificity of pathologic gammaM proteins].

Authors:  O Wetter; K Janke; C Hertenstein
Journal:  Klin Wochenschr       Date:  1966-05-15

7.  Free immunoglobulin light chains in connective tissue diseases.

Authors:  A Cooper; R Bluestone
Journal:  Ann Rheum Dis       Date:  1968-11       Impact factor: 19.103

8.  Serum and urine light chain levels in benign monoclonal gammapathies, multiple myeloma and Waldenström's macroglobulinaemia.

Authors:  F Dammacco; J Waldenström
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

9.  Serum immunoconglutinin levels in human amyloidosis and myelomatosis.

Authors:  T J Muckle
Journal:  Ann Rheum Dis       Date:  1968-11       Impact factor: 19.103

10.  A gamma Bence-Jones protein in guinea pigs.

Authors:  F K Stevenson; L E Mole; C M Raymont; G T Stevenson
Journal:  Biochem J       Date:  1975-12       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.